* B CELL DESIGN *
2008 - Centre
Limoges
www.b-cell-design.com Discover, Drugs
Key words: Humanised antibodies
Mission: to develop, manufacture humanised IgA and IgG antibodies from genetically modified mice
Clients: Clinical labs, Research labs, Medical imaging, Therapists
gael.champier@b-cell-design.com
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.: Sainte-Laudy (Jean) [born 1946, Ph.D. immunology, ex-Pasteur Cerba]
Sc.Dir.: Cuvillier (Armelle)
Techn.Dir.: Champier (Gaël)
Fin.Dir.:
BusDev:
Financers: Limousin Participation, Limousin Expansion, Limousin Business Angels | Turnover (M€) : n.a.
Total funding (M€) : 0.1
Last funding (M€) : 0.1
Focus : Cancers
Position : Proof-of-Concept
Company confirm : neutral |
History | DATE | MILESTONE | TYPE | TIME | | 2008 .03 | Seed financing : 0.1 M€, by Limousin Participation, Limousin Expansion, Limousin Business Angels | SFIN | [0 year] |
| 2008 .01 | Company founded by Michel Cogné (SAB), Armelle Cuvillier, based on a patent from Limoges University | ORGF | [0 year] | Actualisation / Updating: 31-Oct-2008 |
|
